Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Guastalla

7 clinical trials in Guastalla, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Guastalla at a glance
7
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

7 trials in Guastalla

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Azienda USL IRCCS Di Reggio Emilia
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Carboplatin
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:IRCCS Ospedale Policlinico San Martino
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Anastrozole
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Olema Pharmaceuticals Inc.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Guastalla

What the registry says about research in the country

01 Breast Cancer Research

Pioneering research focusing on endocrine-responsive breast cancer treatment optimization. Studies explore the timing and effectiveness of combined chemotherapy and aromatase inhibitors in post-menopausal patients.

  • Treatment Timing Studies
  • Early-Stage Disease Management
  • Hormone Therapy Integration

Advanced trials investigating new therapeutic approaches for patients with ER+/HER2- breast cancer.

02 Metastatic Cancer Studies

Innovative clinical trials evaluating elacestrant compared to standard endocrine therapy for preventing distant metastasis in breast cancer patients with ctDNA markers.

  • Metastasis Prevention
  • Novel Drug Development
  • Biomarker-Based Treatment

Research focusing on improving survival outcomes in advanced disease stages.

03 Colorectal Cancer Research

Comparative studies of treatment combinations for metastatic colorectal cancer, examining the efficacy of targeted therapies including bevacizumab and cetuximab.

  • First-line Treatment Optimization
  • Targeted Therapy Comparison
  • Liquid Biopsy Applications

Investigation of personalized treatment approaches based on molecular profiles.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.